OFVIX | RMEBX | OFVIX / RMEBX | |
Total Expense Ratio | 0.54 | 1.07 | 50% |
Annual Report Gross Expense Ratio | 0.54 | 1.07 | 50% |
Fund Existence | 10 years | 11 years | - |
Gain YTD | 11.747 | 14.628 | 80% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 10000 | 250 | 4,000% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 266M | 113B | 0% |
Annual Yield % from dividends | 1.80 | 1.05 | 171% |
Returns for 1 year | 1.69 | 7.96 | 21% |
Returns for 3 years | 45.46 | 43.02 | 106% |
Returns for 5 years | 85.86 | 58.09 | 148% |
Returns for 10 years | N/A | 92.06 | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
SESLX | 33.43 | N/A | N/A |
1919 Socially Responsive Balanced C | |||
DRLYX | 8.82 | N/A | N/A |
BNY Mellon Developed Markets RE Scs - Y | |||
ALVGX | 11.24 | N/A | N/A |
American Century Focused Lg Cap Val R5 | |||
DSMDX | 20.93 | N/A | N/A |
Driehaus Small/Mid Cap Growth | |||
CGIAX | 45.19 | -0.24 | -0.53% |
American Funds Intl Gr and Inc529A |